SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-006240
Filing Date
2022-03-08
Accepted
2022-03-08 07:15:39
Documents
93
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2428254
2 ex4-1.htm EX-4.1 33526
3 ex4-2.htm EX-4.2 1980
4 ex10-10.htm EX-10.10 101859
5 ex10-19.htm EX-10.19 67474
6 ex10-20.htm EX-10.20 62345
7 ex23-1.htm EX-23.1 3878
8 ex31-1.htm EX-31.1 18118
9 ex31-2.htm EX-31.2 18154
10 ex32-1.htm EX-32.1 7120
11 ex32-2.htm EX-32.2 6996
12 ex4-2_001.jpg GRAPHIC 1407679
13 ex4-2_002.jpg GRAPHIC 497629
  Complete submission text file 0001493152-22-006240.txt   11224050

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE xtnt-20211231.xsd EX-101.SCH 56466
15 XBRL CALCULATION FILE xtnt-20211231_cal.xml EX-101.CAL 86904
16 XBRL DEFINITION FILE xtnt-20211231_def.xml EX-101.DEF 178765
17 XBRL LABEL FILE xtnt-20211231_lab.xml EX-101.LAB 464091
18 XBRL PRESENTATION FILE xtnt-20211231_pre.xml EX-101.PRE 339350
87 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1219361
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34951 | Film No.: 22720321
SIC: 2836 Biological Products, (No Diagnostic Substances)